News

How to fill the gender gap in oncology

The lack of women in apical positions is a weakness of oncology, and a loss for patients. Mentorship programs launched in recent years by scientific societies like ESMO and ASCO, together with practical support for [more]
Big data and precision medicine in cancer: challenges to face

While AI and big data are more and more used to tackle cancer, experts caution: there cannot be exceptionalism for AI in medicine. It requires rigorous studies, publication of the results in peer-reviewed journals, and [more]
Cancer services: how much is enough?

At a time when the search for the ideal recipe of the most effective multidisciplinary approach to cancer care is still on, the life of millions of cancer patients around the world could be saved [more]
I have cancer but I want to work

It is crucial to address disparities and harmonise standards for all European cancer patients. An event at the European Parliament in Brussels, organised by the ABC Global Alliance focused on working rights and policies to protect [more]
Nutrition and cancer: can we really trust experts’ recommendations?

No doubt that diet, as part of a healthy lifestyle, is a pillar of disease prevention and wellbeing, but judging the evidence and coming to strong recommendations in the field is a challenging issue, even for [more]
That’s cancer, a long long time ago

Researchers are turning to mummies and human remains to study cancer, hoping it can inform screening and treatments in the future Modern lifestyle changes, such as smoking or a fast food diet, are often blamed [more]
Whatever happened to the minimum effective dose?

Traditional assumptions about the benefits of higher doses are being challenged as patients demand more emphasis on quality of life and new knowledge emerges about the development of resistance. So why are drug developers still [more]
The Car T cell revolution: what does it offer, and can we afford it?

In August 2018 the first therapies aimed at re-engineering patients own T cells to attack cancer entered the European market. Rachel Brazil looks at how they work, what they achieve, and what the logistical and [more]
Pushing the boundaries of curative treatment: more patients with oligometastatic disease could benefit from local therapies

Is there an early stage in the metastatic process at which the possibility of a cure remains open? Marc Beishon looks at the science, the opportunities opened up by new and more accurate imaging and [more]
How should we assess the efficacy of new treatments in rare tumours?

Traditional approaches to generating clinical evidence rely on recruiting large numbers of patients into trials. Paolo Bruzzi reflects on the challenges of designing and analysing clinical trials in rare cancers, and reviews the potential for [more]